In this signaling pathway, the mammalian target of rapamycin (mTOR) protein-kinase is a master regulator that acts through two complexes: mTORC1 and mTORC2, playing pivotal roles in the induction of tumor growth (10), where aberrant activation of their components is associated with many cancer types (11–13). Here, MTOR is linked to neoplasm.